Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
LOS ANGELES — Pharmaceutical giant Schering-Plough Corp.’s consumer-products unit, Schering-Plough HealthCare Products, has sent requests for proposals to several undisclosed national media agencies for what it is calling an $80 million broadcast buying business, according to sources.
In play, the RFP indicates, are well-known consumer brands such as Dr. Scholl?s foot products and Coppertone suntan lotions, as well as nonprescription drugs such as Afrin decongestants, Lotrimin athlete?s foot treatment and Chlor-Trimeton allergy products. Achenbaum Bogda Associates, New York, is consulting on the review, sources said.
Interpublic
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in